Artificial intelligence is rapidly learning to autonomously design and run biological experiments, but the systems intended ...
Morning Overview on MSN
FDA rejects Replimune’s skin cancer drug again after agency dispute
For the second time, the U.S. Food and Drug Administration has refused to approve Replimune Group’s experimental skin cancer ...
Dr. Jennifer Buell (President, CEO & Director) reiterated MiNK’s differentiation as “an off the shelf” allogeneic iNKT platform that is “administered without lymphodepletion, without HLA matching,” ...
A futuristic indoor bridge inside a modern building in China offers a unique walking experience. Surrounded by glass walls and greenery, the structure blends natural elements with urban architecture, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results